Healthstream (HSTM) Cost of Revenue (2010 - 2026)

Healthstream (HSTM) has reported Cost of Revenue for 17 consecutive years, with $29.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 10.06% year-over-year to $29.0 million in Q2 2026; TTM through Jun 2026 was $112.1 million, a 10.55% increase from a year earlier, with the FY2025 full-year figure at $107.2 million, up 9.47% from the prior year.
• Cost of Revenue was $29.0 million for Q2 2026 at Healthstream, up from $27.8 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $29.0 million in Q2 2026 and troughed at $22.0 million in Q1 2022.
• A 5-year average of $24.9 million and a median of $24.2 million in 2023 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue declined 3.3% in 2022 and gained 14.9% in 2025, its largest moves.
• Over 5 years, Cost of Revenue stood at $23.5 million in 2022, then grew by 2.01% to $24.0 million in 2023, then rose by 4.58% to $25.1 million in 2024, then grew by 14.9% to $28.9 million in 2025, then grew by 0.56% to $29.0 million in 2026.
• The last three Cost of Revenue figures came in at $29.0 million (Q2 2026), $27.8 million (Q1 2026), and $28.9 million (Q4 2025), per Business Quant data.